tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
CalciMedica Halts Phase 2 KOURAGE Trial After Safety Review
PremiumCompany AnnouncementsCalciMedica Halts Phase 2 KOURAGE Trial After Safety Review
2d ago
CalciMedica announces discontinuation of Phase 2 KOURAGE clinical trial
Premium
The Fly
CalciMedica announces discontinuation of Phase 2 KOURAGE clinical trial
2d ago
One new option listing on January 13th
Premium
The Fly
One new option listing on January 13th
17d ago
Calcimedica’s Auxora Study: A Potential Game-Changer for AKI Treatment
PremiumCompany AnnouncementsCalcimedica’s Auxora Study: A Potential Game-Changer for AKI Treatment
3M ago
CalciMedica and Telperian collaborate to integrate AI to Auxora clinical trials
Premium
The Fly
CalciMedica and Telperian collaborate to integrate AI to Auxora clinical trials
4M ago
CalciMedica’s Promising Clinical Advancements and Financial Stability Support Buy Rating
Premium
Ratings
CalciMedica’s Promising Clinical Advancements and Financial Stability Support Buy Rating
6M ago
CalciMedica says cash sufficient to fund operating plan into mid-2026
PremiumThe FlyCalciMedica says cash sufficient to fund operating plan into mid-2026
10M ago
CALC Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
CALC Earnings this Week: How Will it Perform?
10M ago
Promising Phase 2 Results and Market Potential Drive Buy Rating for CalciMedica’s Auxora
Premium
Ratings
Promising Phase 2 Results and Market Potential Drive Buy Rating for CalciMedica’s Auxora
11M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100